Jaguar Health (JAGX) Operating Leases (2019 - 2026)
Jaguar Health (JAGX) reported Operating Leases of $898000.0 for Q1 2026, down 10.02% year-over-year from $998000.0 in Q1 2025, and up 0.67% quarter-over-quarter from $892000.0 in Q4 2025.
Jaguar Health (JAGX) Operating Leases (2019 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 7 years of Operating Leases data on file, last reported at $898000.0 in Q1 2026.
- Operating Leases for Q1 2026 came in at $898000.0, down 10.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $898000.0 (down 10.02% YoY), and the FY2025 annual result was $892000.0, up 30.03% from the prior year.
- Operating Leases improved to $898000.0 in Q1 2026 per JAGX's latest filing, from $892000.0 in the prior quarter.
- Over five years, Operating Leases peaked at $998000.0 in Q1 2025 and troughed at $351000.0 in Q3 2023.
- A 5-year average of $788352.9 and a median of $868000.0 in 2022 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2023 and 2024: Operating Leases tumbled 52.44% in 2023, then soared 114.81% in 2024.
- A 5-year view of Operating Leases shows it stood at $725000.0 in 2022, then rose by 22.21% to $886000.0 in 2023, then retreated by 22.57% to $686000.0 in 2024, then surged by 30.03% to $892000.0 in 2025, then grew by 0.67% to $898000.0 in 2026.
- Business Quant data shows JAGX's Operating Leases at $898000.0 in Q1 2026, $892000.0 in Q4 2025, and $918000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 898,000.00 |
| Dec 31, 2025 | 892,000.00 |
| Sep 30, 2025 | 918,000.00 |
| Jun 30, 2025 | 960,000.00 |
| Mar 31, 2025 | 998,000.00 |
| Dec 31, 2024 | 686,000.00 |
| Sep 30, 2024 | 754,000.00 |
| Jun 30, 2024 | 812,000.00 |
| Mar 31, 2024 | 873,000.00 |
| Dec 31, 2023 | 886,000.00 |
| Sep 30, 2023 | 351,000.00 |
| Jun 30, 2023 | 495,000.00 |
| Mar 31, 2023 | 627,000.00 |
| Dec 31, 2022 | 725,000.00 |
| Sep 30, 2022 | 738,000.00 |
| Jun 30, 2022 | 868,000.00 |
| Mar 31, 2022 | 921,000.00 |
| Dec 31, 2021 | 919,000.00 |
| Sep 30, 2021 | 826,000.00 |
| Jun 30, 2021 | 907,000.00 |